Blau Farmacêutica (B3: BLAU3) revenue
Blau Farmacêutica reported revenue of BRL 1,702m for fiscal 2025, 3.0% less than in fiscal 2024 (BRL 1,754m). Since fiscal 2017 its revenue has grown by 175.6%, an average growth of 13.5% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | BRL 1,702m | −3.0% | BRL 354.4m | 20.8% |
| 2024 | BRL 1,754m | +27.8% | BRL 328.8m | 18.7% |
| 2023 | BRL 1,373m | −2.4% | BRL 329.4m | 24.0% |
| 2022 | BRL 1,407m | +3.0% | BRL 452.2m | 32.1% |
| 2021 | BRL 1,366m | +15.6% | BRL 456.6m | 33.4% |
| 2020 | BRL 1,182m | +20.9% | BRL 389.1m | 32.9% |
| 2019 | BRL 977.5m | +25.0% | BRL 301.5m | 30.8% |
| 2018 | BRL 782.2m | +26.6% | BRL 203.0m | 26.0% |
| 2017 | BRL 617.7m | — | BRL 164.3m | 26.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of Brazilian reais, except per-share amounts.
Questions about the revenue of Blau Farmacêutica
- How much revenue did Blau Farmacêutica make in fiscal 2025?
- Blau Farmacêutica reported revenue of BRL 1,702m for fiscal 2025, compared with BRL 1,754m in fiscal 2024.
- How much has the revenue of Blau Farmacêutica grown?
- Between fiscal 2017 and fiscal 2025 it went from BRL 617.7m to BRL 1,702m: 175.6% more, an average growth of 13.5% a year.
- What was the best year for revenue at Blau Farmacêutica?
- Of its last 9 fiscal years, fiscal 2024, with BRL 1,754m.
- Where do the figures for Blau Farmacêutica come from?
- From the annual financial statements (DFP) that Blau Farmacêutica files with the CVM, the Brazilian securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual financial statements (DFP) that Blau Farmacêutica files with the CVM, the Brazilian securities regulator. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Blau Farmacêutica: the Blau Farmacêutica page · annual accounts · net income · dividends paid.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.